Hartford Reports Strong Q2 Earnings, Announces New $4.2B Share Buyback, and Details Hartford Funds Sale
HIG sits 18% above its 52-week low of $120.33.
Summary
Hartford reported strong Q2 earnings, driven by a tax benefit from the Hartford Funds sale, and authorized a new $4.2 billion share repurchase program, with the stock trading near its 52-week high, though a reinsurance dispute adds a note of caution.
Key Events · Earnings and Guidance · HIG
-
Strong Q2 Earnings
Net income available to common stockholders increased 31% to $1.29 billion, with diluted EPS up 36% to $4.68 for Q2 2026, significantly outperforming the prior year.
-
New $4.2 Billion Share Repurchase Program
The Board approved a new share repurchase authorization for up to $4.2 billion, effective August 1, 2026, through December 31, 2028. This follows $900 million in repurchases during the first half of 2026.
-
Hartford Funds Sale Update
The definitive agreement to sell Hartford Funds to Wellington Management is expected to close in Q1 2027. Q2 results include a $251 million income tax benefit related to establishing a deferred tax asset from this transaction.
-
Reinsurance Dispute
National Indemnity Company (NICO) has suspended payments under an asbestos and environmental reinsurance agreement due to an ongoing arbitration proceeding, which could impact future cash flows or operating results.
Analysis · HIG · Finance
Hartford delivered robust second-quarter results, with significant growth in net income and diluted EPS, largely boosted by a one-time tax benefit from the sale of its Hartford Funds business. This strong performance comes as the stock trades near its 52-week high. The company also announced a substantial new $4.2 billion share repurchase authorization, signaling strong capital return to shareholders. However, a dispute over an asbestos and environmental reinsurance agreement introduces a notable risk.
At the time of this filing, HIG was trading at $142.51 on NYSE in the Finance sector, with a market capitalization of approximately $39B. The 52-week trading range was $120.33 to $144.50. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.